Home › Neurofibrosarcoma › New Jersey
Neurofibrosarcoma clinical trials in New Jersey
3 studies for Neurofibrosarcoma are looking for participants at sites in New Jersey.
Cities in New Jersey
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05245500A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
RecruitingPhase 2
12 Months · All sexes · Updated May 6, 2026 · NCT05985161A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 16 and older · All sexes · Updated Feb 5, 2026 · NCT04872543From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.